Page last updated: 2024-08-24

esreboxetine and Depressive Disorder

esreboxetine has been researched along with Depressive Disorder in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amara, SG; Bonsignori, A; Carfagna, N; Franklin, S; Hoffmann, WP; Hyslop, DK; McArthur, RA; Piercey, MF; Porsolt, RD; Sonders, MS; Tinholt, PM; Wong, EH	1

Other Studies

1 other study(ies) available for esreboxetine and Depressive Disorder

Article	Year
Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. Biological psychiatry, 2000, May-01, Volume: 47, Issue:9 Topics: Adrenergic Uptake Inhibitors; Animals; Brain Chemistry; Carrier Proteins; Cells, Cultured; Conditioning, Operant; Depressive Disorder; Dogs; Dose-Response Relationship, Drug; Electrophysiology; Fluvoxamine; Male; Mice; Morpholines; Norepinephrine; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reboxetine; Receptors, Adrenergic; Reinforcement Schedule; Selective Serotonin Reuptake Inhibitors; Synaptosomes	2000

Article

Year

Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor.

Biological psychiatry, 2000, May-01, Volume: 47, Issue:9

Topics: Adrenergic Uptake Inhibitors; Animals; Brain Chemistry; Carrier Proteins; Cells, Cultured; Conditioning, Operant; Depressive Disorder; Dogs; Dose-Response Relationship, Drug; Electrophysiology; Fluvoxamine; Male; Mice; Morpholines; Norepinephrine; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reboxetine; Receptors, Adrenergic; Reinforcement Schedule; Selective Serotonin Reuptake Inhibitors; Synaptosomes

2000